Mock Transfer Billing: When and How to Charge

A mock embryo transfer — also called a trial transfer, uterine sounding, or practice transfer — is a procedure performed before a frozen embryo transfer (FET) cycle to assess uterine cavity depth, identify anatomic resistance, select the optimal catheter, and document the transfer route before the actual embryo is at risk. Despite its clinical importance, mock transfer is among the most inconsistently billed services in fertility practice. Some clinics bundle it silently into the IVF global fee for all payers; others bill it separately but under the wrong code; still others code it correctly but miss prior authorization because the procedure falls outside the authorized cycle window. Each error pattern either forfeits legitimate revenue or creates compliance exposure that compounds over time.

This guide covers the CPT code options, ICD-10 code selection, prior authorization strategy, modifier use, and documentation standards that govern mock transfer billing — structured for the billing specialist or practice manager responsible for collecting on this frequently overlooked service line.

What a Mock Transfer Is and Why Billing Gets Confused

Clinically, a mock transfer documents the uterine sounding depth in centimeters from the external cervical os to the uterine fundus, identifies any cervical or uterine anatomic resistance, determines which catheter type and curve will seat optimally, and sometimes includes a saline or air bubble instillation to confirm positioning under ultrasound guidance. In ERA (Endometrial Receptivity Array) protocols, the mock transfer also times the endometrial biopsy to the patient's personalized window of implantation, adding a specimen collection component that carries its own CPT code.

The billing confusion stems from three structural problems. First, global fee ambiguity: many practices include mock transfer in their self-pay IVF package or in the global fee negotiated with specific payers — but for payers that reimburse itemized services, the mock transfer must be billed separately or revenue is lost. Second, incorrect code selection: practices default to 58555 (diagnostic hysteroscopy) when no hysteroscope was used, or apply a generic ultrasound code without a separately documented imaging interpretation. Third, cycle timing: mock transfers are frequently performed in a preparatory cycle that precedes the formal FET authorization window, so the authorization letter does not cover the date of service.

CPT Code Selection for Mock Transfer

The most commonly applicable CPT code for a standalone mock embryo transfer is 58340 — Catheterization and introduction of saline or contrast material for the purpose of hysterosonography, hysterosalpingography, or uterine sounding. Although 58340 is most frequently paired with saline infusion sonohysterography (76831), it correctly describes the catheterization and uterine sounding component of a mock transfer when the primary objective is documenting transfer depth and catheter passage. Bill 58340 on its own when no imaging procedure is separately documented and interpreted at the same encounter.

When real-time transvaginal ultrasound is performed at the same encounter — to assess the endometrium or to monitor catheter placement — bill 76830 (Ultrasound, transvaginal) only when the imaging is separately documented with a formal written interpretation. Ultrasound used incidentally to watch catheter position without a separate written report does not support a separate 76830 charge. The ultrasound component requires its own interpretation entry documenting what was visualized, measurements taken, and the clinical impression, signed by the interpreting physician.

When the mock transfer encounter includes deliberate saline infusion into the uterine cavity for simultaneous cavity evaluation — a combined mock transfer plus SIS encounter — bill 58340 plus 76831 together, identical to a standalone SIS claim. Verify payer bundling before submitting: some commercial plans edit 58340 as incidental to 76831 and pay only the imaging code. When the plan does not bundle them, both codes contribute to the claim value and should always be captured.

For mock transfers performed in ERA biopsy protocols — where catheter placement precedes an endometrial biopsy — the correct coding is 58100 (Endometrial sampling, biopsy) for the specimen collection and 58340 for the catheterization and sounding, with modifier 59 on 58340 to distinguish the two separately identifiable services and prevent NCCI bundling. The ERA genetic analysis itself is billed by the reference laboratory under its own proprietary or unlisted code — the practice bills only for the clinical procedures performed in the office.

ICD-10 Code Selection for Mock Transfer

The correct ICD-10 code for a mock transfer claim depends on when in the treatment course the procedure is performed and how the payer classifies ART preparatory services. Using the wrong diagnosis code is one of the most common reasons mock transfer claims are incorrectly routed to the infertility treatment benefit — where they may be subject to cycle limits or dollar caps — when they should be covered under the diagnostic or ART preparatory benefit.

Prior Authorization Strategy for Mock Transfer

Prior authorization management for mock transfer is more nuanced than for the FET cycle itself because of the timing problem described above. The following framework applies across most commercial payer types.

• Confirm payer-specific mock transfer authorization requirements during the initial eligibility and benefits verification call — before the cycle is scheduled. Ask whether mock transfer requires a standalone authorization or is covered within the FET cycle authorization, and document the answer with the call reference number.
• For fertility benefit managers (Progyny, WINFertility, Carrot, Maven), review the provider manual to determine whether mock transfer is explicitly included in the smart cycle or cycle authorization, or whether it is coded as a separate billable encounter requiring its own prior authorization request.
• When the mock transfer precedes the formal FET cycle start date, request authorization specifically for mock transfer before scheduling the procedure. Do not assume the FET authorization covers it — most FET authorizations specify the cycle start date and do not retroactively cover services performed before that date.
• For ERA-specific mock transfers and biopsies, verify separately that the endometrial biopsy component is authorized. Some payers that routinely authorize FET cycles require additional prior authorization for ERA biopsy because it involves a molecular diagnostic test billed by an external laboratory.
• When authorization is denied for mock transfer as a non-covered service, appeal with documentation of clinical necessity — the specific clinical reason why a trial transfer was required (prior failed transfer, clinical suspicion of cervical stenosis, first ART cycle with unknown uterine anatomy, history of intracavitary pathology) — and ASRM guidelines supporting mock transfer as standard of care before embryo transfer.

Modifier Use in Mock Transfer Billing

Correct modifier application is essential in mock transfer billing because multiple services are frequently performed at the same encounter and NCCI bundling edits will combine them without the right modifier flags. The following modifier scenarios occur most frequently in mock transfer claims.

• Modifier 59 on 58340 when billed alongside 58100 (endometrial biopsy) at the same encounter: distinguishes the catheterization and sounding component as a separately identifiable service from the biopsy. Without modifier 59, NCCI edits bundle 58340 into 58100 and pay only the higher-valued code. Both services must be independently documented in the procedure note to support the modifier.
• Modifier 25 on the E&M code when a significant, separately documented E&M service (99213–99215) is billed on the same date as mock transfer: establishes that the office visit involved medical decision-making beyond the pre- and post-service work inherent to the procedure. The E&M note must stand independently, with documented clinical assessment and management decisions separate from the procedure note.
• Modifier 26 on 76831 or 76830 when the imaging study is performed on facility-owned equipment and the practice provides only the professional interpretation: required in hospital outpatient or ambulatory surgery center settings where the technical component is billed by the facility on the UB-04. Submitting the global code in a facility setting creates a duplicate billing conflict.
• Modifier 52 when the mock transfer was attempted but not completed due to cervical stenosis or obstruction: documents that the service was reduced from the full procedure. Do not bill the full procedure fee when the catheter could not be passed and the sounding was not completed. Include a claim notation documenting what was attempted and why the procedure was not completed.
• Modifier 22 when the procedure required significantly extended time and effort — for example, when cervical dilation was required, multiple catheter exchanges were made, or the procedure was prolonged by an anatomic finding not apparent at scheduling. Modifier 22 requires a written explanation submitted with the claim documenting the additional work performed, with a brief quantification of the added time if available.

Global Fee vs. Itemized Billing: When Mock Transfer Is Already Included

Mock transfer is commonly bundled into the self-pay IVF or FET global fee package that practices offer to uninsured patients or patients using financing. When a payer reimburses under a global arrangement — either through a contracted global rate for IVF or FET services or through a fertility benefit manager smart cycle — the mock transfer may already be included in the bundled payment. Submitting a separate claim for mock transfer on top of a global fee arrangement constitutes unbundling and exposes the practice to overpayment demands and compliance audit risk.

The correct approach is to maintain a documented list of what is included in each payer's global arrangement and what is separately billable. Most practices need a payer-by-payer matrix: for some payers (self-pay, certain contracted plans), mock transfer is inside the global; for others (most commercial indemnity plans), it is billed at the itemized fee schedule rate. The charge description master must reflect mock transfer as a discrete billable line item so the practice can activate it for itemizing payers without changing the charge workflow for global-fee payers.

Documentation Requirements That Support Mock Transfer Claims

Mock transfer procedure notes are frequently minimal — a brief notation of the sounding depth and catheter used — because the procedure itself takes only a few minutes. But a minimal note does not survive payer review or audit. The following elements must appear in the procedure documentation to support the claim.

• Clinical indication: the specific reason this patient required a mock transfer before the planned embryo transfer — first ART cycle with no prior transfer history, history of prior failed transfer, clinically suspected cervical stenosis, known uterine anomaly, or other documented clinical rationale. A note that records the procedure finding without documenting why the procedure was performed is incomplete and will not satisfy medical necessity review.
• Uterine sounding depth in centimeters: document the sounding depth from the external cervical os to the fundus. This finding directly informs transfer catheter length selection and is the primary clinical data point from the procedure. A claim for 58340 without this measurement in the note is difficult to defend on audit.
• Catheter type and curve selected: document the catheter manufacturer, model, and curve used during the mock transfer, and state whether this will be the selected catheter for the actual embryo transfer. Catheter selection documentation demonstrates that the procedure served a clinical planning function and not merely a routine preliminary step.
• Cervical findings: document the presence or absence of cervical resistance, any dilation performed, how many catheter passes were required, and any anatomic findings (cervical polyp visualized, stenotic os, extreme uterine angulation) that affected the procedure.
• Ultrasound findings: if transvaginal ultrasound is billed as 76830, document a separate interpretation section listing endometrial thickness, echo pattern, endometrial stripe measurement, and ovarian findings with a clinical impression signed by the interpreting physician. A brief mention of ultrasound use in the procedural narrative does not satisfy the interpretation requirement.
• For ERA biopsy encounters: the procedure note must document the mock transfer catheter placement, biopsy cannula introduction, endometrial specimen obtained, and the ERA laboratory requisition submitted. The biopsy component (58100) must be documented distinctly enough to establish it as a separately identifiable service from the mock transfer sounding (58340).

Common Mock Transfer Denial Reasons and Resolution

Mock transfer claims follow a predictable denial pattern. The table below maps the most common denial reason codes to their root causes and resolution paths.

ERA Protocol Billing: A Special Case for Mock Transfer

ERA testing has become a standard add-on at many fertility practices for patients who have experienced implantation failure or who elect testing proactively. The ERA mock transfer visit is procedurally distinct from a routine mock transfer because it always includes an endometrial biopsy, and the precise timing of the mock transfer relative to the patient's progesterone-stimulated cycle is the clinical purpose of the encounter.

Bill the ERA mock transfer visit with 58100 for the biopsy and 58340 with modifier 59 for the catheterization and sounding. The ERA laboratory (Igenomix, CooperGenomics, or other vendors) handles billing for the genetic analysis itself under its own codes. The practice bills only for the clinical procedures performed in the office. Counsel patients before the visit that the laboratory analysis carries a separate charge — and that the laboratory bill arrives under the lab's own NPI and tax ID, not the practice's — to prevent patient confusion that escalates to billing disputes.

Some payers have implemented prior authorization requirements specifically for ERA testing, distinct from standard IVF/FET authorization, in response to the 2022–2024 evidence debates about ERA's clinical utility in unselected populations. Before scheduling an ERA mock transfer visit, verify whether the payer requires ERA-specific prior authorization. An authorization covering the FET cycle generally does not automatically cover ERA testing — obtain explicit written or documented verbal confirmation.

Building a Reliable Mock Transfer Billing Workflow

Consistent mock transfer revenue requires treating the procedure as a discrete billable encounter — not an informal preparatory step absorbed into the cycle visit. The following process elements should be verified and maintained as part of the practice's billing workflow.

• The scheduling system flags mock transfer as a billable encounter with its own charge capture workflow — distinct from the FET consultation or cycle monitoring visit — so the procedure does not fall through to an unbilled encounter.
• The CDM lists 58340 as a discrete charge item with its own procedure fee, not bundled into a general "office procedure" line. A CDM that does not separately list 58340 makes it impossible to track utilization or systematically apply authorization rules to the service.
• The eligibility and authorization team includes mock transfer in the authorization inquiry for every ART cycle, documenting both whether it is covered under the cycle authorization and what the effective start date of coverage is.
• For ERA cycles, the biopsy is co-scheduled with the mock transfer at the time of cycle planning, and the ERA-specific prior authorization workflow is triggered concurrently with the FET cycle authorization request.
• Procedure notes are templated to capture all required documentation elements — clinical indication, sounding depth in centimeters, catheter selection, cervical findings, and ultrasound interpretation when applicable — so billing staff receive complete documentation at the time of charge entry and do not need to chase the provider for addenda.

Mock transfer is a clinically important, separately reimbursable service that most fertility practices under-bill relative to its actual occurrence rate. With the right CPT codes, correct ICD-10 selection, a proactive authorization workflow, proper modifier application, and complete procedure documentation, the practice collects revenue that currently goes uncollected — without ordering additional services or increasing patient burden. That is the most straightforward revenue cycle gain available to most fertility billing operations, and it starts with treating the mock transfer as the distinct, billable clinical service it actually is.